Cargando…

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience

INTRODUCTION Glomerular hyperfiltration has long been considered to be a major contributing factor to the development of diabetic kidney disease but most studies assessed increased albumin excretion rather than reduced GFR as an outcome. To address whether early glomerular hyperfiltration results in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molitch, Mark, Gao, Xiaoyu, Bebu, Ionut, De Boer, Ian, Lachin, John, Paterson, Andrew, Perkins, Bruce, Saenger, Amy, Steffes, Michael, Zinman, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555076/ http://dx.doi.org/10.1210/js.2019-OR14-4

Ejemplares similares

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2019)

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2020)

Serum urate and cardiovascular events in the DCCT/EDIC study
por: Jenkins, Alicia J., et al.
Publicado: (2021)

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
por: Braffett, Barbara H., et al.
Publicado: (2019)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

Coronary Artery Disease Events and Carotid Intima‐Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort
por: Polak, Joseph F., et al.
Publicado: (2021)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study
por: Darabian, Sirous, et al.
Publicado: (2016)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Chronic Kidney Disease Prevalence and Glomerular Filtration Rate Trends in Children With Type 1 Diabetes
por: Favel, Kristen, et al.
Publicado: (2021)

OR22-4 Recurrent Hypoglycemia, Fragmentation of Care, and Mortality in Chicago
por: O'Connor, Clare, et al.
Publicado: (2019)

Biomarkers of tubulointerstitial damage and function in type 1 diabetes
por: de Boer, Ian H, et al.
Publicado: (2017)

SUN-687 MODY-14: A Rare Cause of Inherited Diabetes
por: Epp, Riley, et al.
Publicado: (2020)

OR14-04 A Novel ERRα-Dependent Insulin Signaling Pathway
por: Xia, Hui, et al.
Publicado: (2020)

OR14-6 The Role of the Angiopoietin-Tie2 Pathway in Microvascular Complications of Diabetes Mellitus
por: Brigell, Mitchell, et al.
Publicado: (2019)

OR14-02 Circadian Regulation of Chromatin State Mediates Pancreatic Islet Incretin Response
por: Weidemann, Benjamin John, et al.
Publicado: (2020)

OR14-03 The Transcriptional Coactivation Function of EHMT2 Restricts Chronic Glucocorticoid Exposure Induced Insulin Resistance
por: Lee, Rebecca Arwyn, et al.
Publicado: (2020)

OR14-2 Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
por: Dandona, Paresh, et al.
Publicado: (2019)

OR14-07 Association Between Placental Glucose Uptake and Protein O-Glcnacylation and Birth Outcomes in Obese Non-Diabetic Mothers
por: Panetta, Pamela, et al.
Publicado: (2020)

OR14-01 FSTL3 Neutralizing Antibodies Restore Function to Diabetic Mouse and Human Islets: A New Approach for Treating Diabetes
por: Schneyer, Alan, et al.
Publicado: (2020)

OR14-05 Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice
por: Muratalla, Jose T, et al.
Publicado: (2020)

OR14-5 Challenges in implementing Hybrid Closed Loop Insulin Pump Therapy (medtronic 670g) In A 'Real World' Clinical Setting.
por: Goodwin, Gregory, et al.
Publicado: (2019)

OR14-06 Inhibition of Protein Kinase C-beta2 Phosphorylation Restores Nuclear Factor-Kappa B Activation and Improves Peripheral Arterial Disease in Diabetes
por: Alleboina, Satyanarayana, et al.
Publicado: (2020)

MON-673 Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-Alcoholic Steatohepatitis
por: DeBoer, Mark Daniel, et al.
Publicado: (2020)

OR14-1 Pharmacodynamics, Safety, Tolerability, and Efficacy of Oral Insulin Formulation (Oshadi Icp) among Young Adults with Type 1 Diabetes: A Summary of Clinical Studies Phases I, Ib, and Ii
por: Rachmiel, Marianna, et al.
Publicado: (2019)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study
por: Tang, W.H. Wilson, et al.
Publicado: (2018)

Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657–664
por: Braffett, Barbara H., et al.
Publicado: (2019)

Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2017)

MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

MON-158 Association between Famine Exposure in Early Life with Insulin Resistance and β-cell Dysfunction in Adulthood
por: Wang, Yuying, et al.
Publicado: (2019)

MON-159 Increased Gluconeogenesis and Lower Glycogenolysis in Patients with Non-Selective Compared Selective Insulin Resistance
por: Sekizkardes, Hilal, et al.
Publicado: (2019)

MON-164 The Non-insulin-based METS-IR Index Combined With Liver Transaminases Improves Prediction Of Fatty Liver And Fibrosis
por: Bello-Chavolla, Omar, et al.
Publicado: (2019)

MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
por: Espinoza-Derout, Jorge, et al.
Publicado: (2019)

MON-150 Phone Call Reminders and Mobile Health Apps: Do They Help Our Diabetic Patients?
por: Lu, Kevin, et al.
Publicado: (2019)

MON-182 Adaptable Amperometric Biosensor Platforms for the Diagnosis of Endocrine Disorders
por: Labban, Najwa, et al.
Publicado: (2019)

MON-129 An Unusual LMNA Mutation Causing a Complex Phenotype: When the Genetic Diagnosis Uncovers Novel Features
por: Andrade, Natália, et al.
Publicado: (2019)

MON-178 Vitamin D Treatment of Patients with Type 1 Diabetes Reduces RORy, FoxP3 and CD4 Gene Expression in T Helper Cells
por: Penna-Martinez, Marissa, et al.
Publicado: (2019)

MON-154 Abnormal Glucose Homeostasis in Spinal Muscular Atrophy (SMA) Leading to a Transient Episode of Diabetic Ketoacidosis (DKA)
por: Hossain, Sabina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sujcpbu9gdafsa67bmq9nsb841